AGP Executive Report
Last update: 9 hours agoBiotech: Wilmington-based Incyte will present new oncology findings at the European Society for Medical Oncology Congress, including data on experimental treatments for colorectal and pancreatic cancers. Industrial Watch: Chemours faces a securities-fraud class action alleging it misrepresented demand for its Opteon refrigerants; the company has not been found liable. Food and Drug Oversight: Veterinary businesses received Delaware’s most FDA inspections in September: two companies accounted for half of the month’s inspections, and Tail Bangers received the most citations. Workforce: Delaware retail employers filed 21 H-1B petitions in 2025, up 10.5% from 2024; statewide, manufacturers filed 196. Transportation Standards: Delaware is seeking public comment through Nov. 2 on new safety and construction rules for school buses built from 2027. The proposal includes child-reminder systems and speed governors.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
Pseudo-journalism: Pink-slime
